Suresh Mahadevan

The launch of Reliance Jio, thanks to its focus on cheap data plans, is going to significantly expand India's data market, leading to an opportunity even for its large rivals, says Suresh Mahadevan of UBS.

Telecom consolidation is the writing on the wall:UBS's Mahadevan

Suresh Mahadevan, ‎Managing Director - Head of Asian Telecom and Media research at UBS AG, told CNBC-TV18 that the brokerage is bullish on the telecom space owing to the huge data growth opportunity it presents to telcos.

4G data pack price cut to boost telcos' revenue: UBS AG

Telecom stocks have been under pressure lately as industry majors Airtel and Idea announced a major price cut for their data plans, ahead of Reliance Jio's launch on August 15.

Rapid data growth to boost telecom industry: UBS AG

The big picture for the sector is surrounded by rapid growth in data consumption, revenue growth and EBITDA margins expansion, says Suresh Mahadevan of UBS AG.

Is Re 1/call compensation best way to nip call drop menace?

According to the new rules imposed by Trai, telecom operators will have to compensate its users by paying Re 1 for every call dropped from January 1, 2016, and limit it to a maximum of three calls dropped per day

TTML appoints Harish Abhichandani as CFO

Tata Teleservices (Maharashtra) Ltd (TTML) on Friday said it has appointed Harish Abhichandani as Chief Financial Officer with effect from September 1.

Rel Jio's entry to bring in affordable data pricing: UBS AG

UBS Evidence Lab had conducted a survey of 1250 wireless subscribers aged between 18 and 75, residing in five major cities and six out of ten customers indicated a lack of interest in Jio.

Spectrum auction: UBS AG sees 900 MHz at 60% premium

Suresh Mahadevan expects 900 MHz to settle at 60 percent premium. He sees Bharti and Idea spending little over Rs 18,000 crore and Rs 24,000 crore respectively.

Bharti Airtel's India data growth robust, maintain buy: UBS

Bharti Airtel surpassed street expectations on the bottomline front on Wednesday but its Q3 topline and operating performance was slightly below estimates.

Govt reaction to spectrum sale positive: UBS

Data consumption is growing significantly and digital India is a priority for prime minister Narendra Modi and hence more spectrum is likely to come to the market, which is a positive, Suresh Mahadevan of UBS says.

Suresh Mahadevan positive on Bharti Airtel

Suresh Mahadevan, Head of Asian Telecom at UBS Securities is positive on Bharti Airtel and Idea Cellular.

Bharti's Africa biz to show better result in FY16: UBS

Going forward, Suresh Mahadevan of UBS Securities believes Africa will start showing better results considering it is more emerging than India and there is no shortage of spectrum there.

Bharti up 3% post Q3 nos; Analysts say buy more

Suresh Mahadevan of UBS AG is positive on Bharti Airtel. He feels the stock may touch Rs 420. According to him, the February 3 spectrum auction could emerge as a positive catalyst especially if there are no big fireworks like a lot of investors are worried about.

Bharti Airtel may move to Rs 420: Suresh Mahadevan

According to Suresh Mahadevan of UBS AG, Bharti Airtel may move to Rs 420.

Remain upbeat on Bharti Airtel; target price Rs 420/Sh: UBS

Suresh Mahadevan of UBS AG continues to be positive on telecom player Bharti Airtel with a target price of Rs 420/share. Sharing views on the recent management rejig at the company, he said that Bharti is bold enough to change leadership in India and Africa and Gopal Vittal now the CEO & MD, India and South Asia will be positive influence.

Idea, Bharti Airtel likely to do well: Suresh Mahadevan

Suresh Mahadevan, Head-Asia Telecom at UBS AG feels that Idea Cellular and Bharti Airtel are likely to do well over the next two-three years.

Bharti, Idea, Voda to rule telecom, consolidation soon: UBS

UBS AG's Suresh Mahadevan is hopeful that the upcoming auctions in December-January will go through smoothly. However, he says that Wednesday's announcements from the Telecom Commission were not very material.

Prefer Exide Industries over Apollo Tyres: UBS

Suresh Mahadevan, MD & Head of Indian Equities at UBS Securities prefers Exide Industries over Apollo Tyres.

UBS maintains target of Rs 420 on Bharti Airtel

Suresh Mahadevan, MD & Head of Indian Equities at UBS Securities is of the view that Bharti Airtel can touch Rs 420 over the next 12 months.

Bearish on Jubilant Foodworks: Suresh Mahadevan

Suresh Mahadevan, MD & Head of Indian Equities at UBS Securities is negative on Jubilant Foodworks and feels there will be more downside in it.

Prefer Dr Reddys, Sun Pharma: Suresh Mahadevan

One can prefer Dr Reddys Laboratories, Sun Pharma over Ranbaxy, says Suresh Mahadevan, MD & Head of Indian Equities at UBS Securities.

Not worried about Re; bet on Exide, Sun Pharma, Bharti: UBS

Suresh Mahadevan, MD & Head of Indian Equities, UBS Securities is of the opinion that Nifty will end 2013, at higher end of 5600-6450 range and sees FY14 earnings growth being slightly lower than 15-16%.

Cyprus to hurt sentiment in short-term; buy CIL, Exide: UBS

The Cyprus bailout deal issue may have an impact on the market just for the short-term. Infact, this correction presents an opportunity for long term investors to accumulate blue chips, believes Suresh Mahadevan, MD & head of Indian equities, UBS Securities.

Positive on Phoenix Mills: UBS Securities

Suresh Mahadevan, MD & Head of Indian Equities of UBS Securities is positive on Phoenix Mills.

Negative on Crompton Greaves, says UBS Securities

Suresh Mahadevan, MD & Head of Indian Equities of UBS Securities is negative on Crompton Greaves as the data point continues to disappoint.